From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

RELX – crazy name but (grudgingly I accept) a good business...

By Chris Bailey | Thursday 22 October 2020


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Call me a complete weirdo, but there is something about the name RELX (REL) which completely gets on my goat. There are a couple of reasons for this, but the only one I am going to share with you is that I thought the old name of Reed Elsevier is far classier. I wonder what the bill was (way back in 2015!) for thinking up the new name? All I know is, when you (still) have to provide a pronunciation guide (“REL-EX” if you were wondering), it ain’t a good look. Anyhow, the ‘X-factor’ of just sticking the twenty-fourth letter of the alphabet at the end of a logical name is so…2015 but I have to grudgingly admit that the company – which describes itself as a ‘global provider of information-based analytics and decision tools for professional and business customers’ – is a good ‘un…

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

Time left: 05:26:11